Most boys treated with breakthrough gene therapy for a rare but deadly brain illness are faring well six years later, two new ...

A Bluebird Bio gene therapy has helped children with a devastating neurological disorder, but seven have developed blood ...

Since the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked.

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a ...

A new gene drive can copy and paste itself into the genomes of herpes simplex viruses in mice. The end goal is a version that disables the virus in humans.

Despite previous attempts to treat these diseases through gene therapy, success has been limited due to immune responses to current therapies. Prime editing could change this by enabling permanent ...

Researchers will develop therapies for urea cycle disorders and create a platform to rapidly develop treatments for other rare genetic disorders.

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

The offering will fund testing of a potential rival to Amgen’s Tezpire and is already the sixth for an immune drug developer this year, the most since 2021.

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

The Psychobiological Approach to Couple Therapy® is a cohesive approach derived from research in three areas: developmental neuroscience, attachment theory, and arousal regulation. Neuroscience ...

After an epic election defeat in July, opposition lawmakers have presented their party’s dues-paying members with an unexpected choice of two candidates from the right. By Mark Landler and ...